Treatment with 1 μM ATO did not change the oxidative balance of the cells, whereas 3 mM ASC, alone or in combination with 1 μM ATO, resulted in an immediate outburst of ROS in CD34+ cells from AML specimens. This evidence concerns the gene CD34 and acute myeloid leukemia.